Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma.

Yoneda M, Suzuki T, Nakamura T, Ajima R, Yoshida Y, Kakuta S, Katsuko S, Iwakura Y, Shibutani M, Mitsumori K, Yokota J, Yamamoto T.

Cancer Sci. 2009 Feb;100(2):225-32. doi: 10.1111/j.1349-7006.2008.01030.x.

2.

Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.

Takemoto N, Tada M, Hida Y, Asano T, Cheng S, Kuramae T, Hamada J, Miyamoto M, Kondo S, Moriuchi T.

Lung Cancer. 2007 Dec;58(3):376-83.

PMID:
17714826
3.

Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.

Wu MH, Hong TM, Cheng HW, Pan SH, Liang YR, Hong HC, Chiang WF, Wong TY, Shieh DB, Shiau AL, Jin YT, Chen YL.

Mol Cancer Res. 2009 Mar;7(3):311-8. doi: 10.1158/1541-7786.MCR-08-0297.

4.

Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.

Tao Q, Fujimoto J, Men T, Ye X, Deng J, Lacroix L, Clifford JL, Mao L, Van Pelt CS, Lee JJ, Lotan D, Lotan R.

J Natl Cancer Inst. 2007 Nov 21;99(22):1668-82.

PMID:
18000218
5.

Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells.

Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, Mitsuoka M, Sato T, Hayashi S, Izumi H, Tsuneoka M, Sueoka E.

J Cancer Res Clin Oncol. 2010 Mar;136(3):465-73. doi: 10.1007/s00432-009-0679-0.

PMID:
19756735
6.

[Exogenous expression of SOCS box-deficient mutant ASB-8 suppresses the growth of lung adenocarcinoma SPC-A1 cells].

Liu YZ, Li JJ, Zhang FR, Shen Y, Yao M, Wan DF, Gu JR.

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Jun;35(6):548-53. Chinese.

7.

Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line.

Gemma A, Takenaka K, Hosoya Y, Matuda K, Seike M, Kurimoto F, Ono Y, Uematsu K, Takeda Y, Hibino S, Yoshimura A, Shibuya M, Kudoh S.

Eur J Cancer. 2001 Aug;37(12):1554-61.

PMID:
11506965
8.

Posttranscriptional regulation of plasminogen activator inhibitor-1 in human lung carcinoma cells in vitro.

Shetty S, Idell S.

Am J Physiol Lung Cell Mol Physiol. 2000 Jan;278(1):L148-56.

9.

Integrin alpha 11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells.

Zhu CQ, Popova SN, Brown ER, Barsyte-Lovejoy D, Navab R, Shih W, Li M, Lu M, Jurisica I, Penn LZ, Gullberg D, Tsao MS.

Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11754-9.

10.

Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition.

Oh SH, Lee OH, Schroeder CP, Oh YW, Ke S, Cha HJ, Park RW, Onn A, Herbst RS, Li C, Lee HY.

Mol Cancer Ther. 2006 Nov;5(11):2685-95.

11.

Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.

Cohen AJ, Bunn PA, Franklin W, Magill-Solc C, Hartmann C, Helfrich B, Gilman L, Folkvord J, Helm K, Miller YE.

Cancer Res. 1996 Feb 15;56(4):831-9.

12.

Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.

Nishikawa A, Iwasaki M, Akutagawa N, Manase K, Yamashita S, Endo T, Kudo R.

Gynecol Oncol. 2000 Nov;79(2):256-63.

PMID:
11063654
13.

Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma.

Aviel-Ronen S, Lau SK, Pintilie M, Lau D, Liu N, Tsao MS, Jothy S.

Mod Pathol. 2008 Jul;21(7):817-25. doi: 10.1038/modpathol.2008.37.

14.

Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.

Zhang L, Ding F, Cao W, Liu Z, Liu W, Yu Z, Wu Y, Li W, Li Y, Liu Z.

Clin Cancer Res. 2006 Mar 1;12(5):1639-46.

16.
17.

Cyclophosphamide promotes pulmonary metastasis on mouse lung adenocarcinoma.

Man S, Zhang Y, Gao W, Yan L, Ma C.

Clin Exp Metastasis. 2008;25(8):855-64. doi: 10.1007/s10585-008-9201-3.

PMID:
18766303
18.

Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.

Hayashi M, Tokuchi Y, Hashimoto T, Hayashi S, Nishida K, Ishikawa Y, Nakagawa K, Tsuchiya S, Okumura S, Tsuchiya E.

Anticancer Res. 2001 Jan-Feb;21(1B):535-40.

PMID:
11299800
19.

Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.

Xu HT, Wei Q, Liu Y, Yang LH, Dai SD, Han Y, Yu JH, Liu N, Wang EH.

Ann Surg Oncol. 2007 Nov;14(11):3251-9.

PMID:
17768662
20.

Supplemental Content

Support Center